Monogenic diabetes in New Zealand - An audit based revision of the monogenic diabetes genetic testing pathway in New Zealand.

Frontiers in endocrinology(2023)

Cited 1|Views8
No score
Abstract
A new monogenic diabetes testing algorithm for NZ is proposed, which directs clinicians to choose a large gene panel in patients without syndromic features who score a pre-test MODY probability of above 20%.
More
Translated text
Key words
Aotearoa (New Zealand),MODY,New Zealand,genetic testing,genomics,monogenic diabetes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined